NO131834B - - Google Patents
Download PDFInfo
- Publication number
- NO131834B NO131834B NO3148/69A NO314869A NO131834B NO 131834 B NO131834 B NO 131834B NO 3148/69 A NO3148/69 A NO 3148/69A NO 314869 A NO314869 A NO 314869A NO 131834 B NO131834 B NO 131834B
- Authority
- NO
- Norway
- Prior art keywords
- hydroxy
- methoxy
- methyl
- pyrrolidylmethyl
- xylene
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims description 22
- 150000003839 salts Chemical class 0.000 claims description 8
- -1 heterocyclic benzamides Chemical class 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 150000002148 esters Chemical class 0.000 claims description 3
- 230000001225 therapeutic effect Effects 0.000 claims description 3
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 claims description 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 229940054066 benzamide antipsychotics Drugs 0.000 claims description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 2
- 229910052794 bromium Chemical group 0.000 claims description 2
- 239000000460 chlorine Substances 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 17
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 13
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 13
- 239000008096 xylene Substances 0.000 description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- 239000000203 mixture Substances 0.000 description 10
- 238000002844 melting Methods 0.000 description 7
- 230000008018 melting Effects 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 230000003474 anti-emetic effect Effects 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 6
- 239000007787 solid Substances 0.000 description 5
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 4
- 150000001412 amines Chemical class 0.000 description 4
- VMWNQDUVQKEIOC-CYBMUJFWSA-N apomorphine Chemical compound C([C@H]1N(C)CC2)C3=CC=C(O)C(O)=C3C3=C1C2=CC=C3 VMWNQDUVQKEIOC-CYBMUJFWSA-N 0.000 description 4
- 229960004046 apomorphine Drugs 0.000 description 4
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- DRSHXJFUUPIBHX-UHFFFAOYSA-N COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 Chemical compound COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 DRSHXJFUUPIBHX-UHFFFAOYSA-N 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 235000011054 acetic acid Nutrition 0.000 description 2
- 230000007059 acute toxicity Effects 0.000 description 2
- 231100000403 acute toxicity Toxicity 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 239000002111 antiemetic agent Substances 0.000 description 2
- GZUXJHMPEANEGY-UHFFFAOYSA-N bromomethane Chemical compound BrC GZUXJHMPEANEGY-UHFFFAOYSA-N 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- JZMYRQHKOYJYQO-UHFFFAOYSA-N methanol;1,2-xylene Chemical class OC.CC1=CC=CC=C1C JZMYRQHKOYJYQO-UHFFFAOYSA-N 0.000 description 2
- TTWJBBZEZQICBI-UHFFFAOYSA-N metoclopramide Chemical compound CCN(CC)CCNC(=O)C1=CC(Cl)=C(N)C=C1OC TTWJBBZEZQICBI-UHFFFAOYSA-N 0.000 description 2
- 229960004503 metoclopramide Drugs 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 235000009518 sodium iodide Nutrition 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- UNRBEYYLYRXYCG-UHFFFAOYSA-N (1-ethylpyrrolidin-2-yl)methanamine Chemical compound CCN1CCCC1CN UNRBEYYLYRXYCG-UHFFFAOYSA-N 0.000 description 1
- TZFATUOLQKYADA-UHFFFAOYSA-N (1-propylpyrrolidin-2-yl)methanamine Chemical compound CCCN1CCCC1CN TZFATUOLQKYADA-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- KOWANBRZFLSWFZ-UHFFFAOYSA-N 5-chloro-n-[(1-ethylpyrrolidin-2-yl)methyl]-4-hydroxy-2-methoxybenzamide Chemical compound CCN1CCCC1CNC(=O)C1=CC(Cl)=C(O)C=C1OC KOWANBRZFLSWFZ-UHFFFAOYSA-N 0.000 description 1
- FHUKMJGACMEEKS-UHFFFAOYSA-N 5-chloro-n-[(1-ethylpyrrolidin-2-yl)methyl]-4-hydroxy-2-methoxybenzamide;hydrochloride Chemical compound Cl.CCN1CCCC1CNC(=O)C1=CC(Cl)=C(O)C=C1OC FHUKMJGACMEEKS-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-M Methanesulfonate Chemical compound CS([O-])(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-M 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 229940125683 antiemetic agent Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 1
- 229940073608 benzyl chloride Drugs 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 229940071221 dihydroxybenzoate Drugs 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- PHYPTZODBQEMJU-UHFFFAOYSA-N methyl 2-hydroxy-4-phenylmethoxybenzoate Chemical compound C1=C(O)C(C(=O)OC)=CC=C1OCC1=CC=CC=C1 PHYPTZODBQEMJU-UHFFFAOYSA-N 0.000 description 1
- 229940102396 methyl bromide Drugs 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000001226 reprecipitation Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000003033 spasmogenic effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
- C07C45/54—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition of compounds containing doubly bound oxygen atoms, e.g. esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
- C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
- C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR161593A FR7707M (OSRAM) | 1968-08-01 | 1968-08-01 | |
| FR171761 | 1968-10-29 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO131834B true NO131834B (OSRAM) | 1975-05-05 |
| NO131834C NO131834C (OSRAM) | 1975-08-13 |
Family
ID=26182167
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO3148/69A NO131834C (OSRAM) | 1968-08-01 | 1969-07-31 |
Country Status (22)
| Country | Link |
|---|---|
| JP (1) | JPS4837267B1 (OSRAM) |
| BE (1) | BE736560A (OSRAM) |
| BG (1) | BG17299A3 (OSRAM) |
| BR (1) | BR6911217D0 (OSRAM) |
| CA (1) | CA955949A (OSRAM) |
| CH (1) | CH507938A (OSRAM) |
| DE (2) | DE1937515C3 (OSRAM) |
| DK (1) | DK142844B (OSRAM) |
| ES (1) | ES369930A1 (OSRAM) |
| FI (1) | FI52214C (OSRAM) |
| GB (1) | GB1234118A (OSRAM) |
| IE (1) | IE33541B1 (OSRAM) |
| IL (1) | IL32712A (OSRAM) |
| LU (1) | LU59176A1 (OSRAM) |
| MC (1) | MC806A1 (OSRAM) |
| NL (1) | NL142410B (OSRAM) |
| NO (1) | NO131834C (OSRAM) |
| OA (1) | OA03889A (OSRAM) |
| PH (1) | PH11002A (OSRAM) |
| RO (1) | RO55778A (OSRAM) |
| SE (1) | SE359830B (OSRAM) |
| YU (1) | YU34289B (OSRAM) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5212117U (OSRAM) * | 1975-07-15 | 1977-01-27 | ||
| IL52645A (en) * | 1976-08-05 | 1980-02-29 | Synthelabo | Optically active 1 substituted 2 aminomethyl pyrrolidines stereospecifics synthesis thereof and process for the preparation of optically active 2 methoxy n pyrrolidylmethyl benzamides |
| SE8101536L (sv) * | 1981-03-11 | 1982-09-12 | Astra Laekemedel Ab | Bensamid-derivat |
| SE8205135D0 (sv) * | 1982-09-09 | 1982-09-09 | Astra Laekemedel Ab | Benzamido-derivatives |
-
1969
- 1969-07-21 CH CH1115769A patent/CH507938A/fr not_active IP Right Cessation
- 1969-07-23 OA OA53680A patent/OA03889A/xx unknown
- 1969-07-23 DE DE1937515A patent/DE1937515C3/de not_active Expired
- 1969-07-23 DE DE19691966215 patent/DE1966215A1/de not_active Withdrawn
- 1969-07-24 IE IE1027/69A patent/IE33541B1/xx unknown
- 1969-07-24 SE SE10434/69A patent/SE359830B/xx unknown
- 1969-07-25 MC MC834A patent/MC806A1/fr unknown
- 1969-07-25 BE BE736560D patent/BE736560A/xx not_active IP Right Cessation
- 1969-07-26 BG BG012749A patent/BG17299A3/xx unknown
- 1969-07-26 ES ES369930A patent/ES369930A1/es not_active Expired
- 1969-07-27 IL IL32712A patent/IL32712A/xx unknown
- 1969-07-28 GB GB1234118D patent/GB1234118A/en not_active Expired
- 1969-07-28 LU LU59176D patent/LU59176A1/xx unknown
- 1969-07-29 YU YU1965/69A patent/YU34289B/xx unknown
- 1969-07-29 FI FI692247A patent/FI52214C/fi active
- 1969-07-30 CA CA058,341*7A patent/CA955949A/en not_active Expired
- 1969-07-31 NL NL696911713A patent/NL142410B/xx not_active IP Right Cessation
- 1969-07-31 BR BR211217/69A patent/BR6911217D0/pt unknown
- 1969-07-31 NO NO3148/69A patent/NO131834C/no unknown
- 1969-07-31 JP JP44060979A patent/JPS4837267B1/ja active Pending
- 1969-07-31 DK DK414169AA patent/DK142844B/da not_active IP Right Cessation
- 1969-08-01 RO RO60706A patent/RO55778A/ro unknown
-
1973
- 1973-05-02 PH PH14575A patent/PH11002A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE1937515A1 (de) | 1970-07-02 |
| IL32712A (en) | 1973-06-29 |
| DE1937515B2 (de) | 1980-06-12 |
| IL32712A0 (en) | 1969-09-25 |
| BE736560A (OSRAM) | 1970-01-26 |
| OA03889A (fr) | 1975-08-14 |
| BR6911217D0 (pt) | 1973-02-15 |
| NO131834C (OSRAM) | 1975-08-13 |
| NL6911713A (OSRAM) | 1970-02-03 |
| PH11002A (en) | 1977-10-20 |
| RO55778A (OSRAM) | 1974-02-01 |
| YU196569A (en) | 1978-10-31 |
| MC806A1 (fr) | 1970-07-30 |
| IE33541B1 (en) | 1974-08-07 |
| BG17299A3 (bg) | 1973-07-25 |
| LU59176A1 (OSRAM) | 1970-01-28 |
| SE359830B (OSRAM) | 1973-09-10 |
| CA955949A (en) | 1974-10-08 |
| DE1937515C3 (de) | 1981-02-19 |
| IE33541L (en) | 1970-02-01 |
| GB1234118A (OSRAM) | 1971-06-03 |
| DK142844B (da) | 1981-02-09 |
| FI52214C (fi) | 1977-07-11 |
| JPS4837267B1 (OSRAM) | 1973-11-09 |
| ES369930A1 (es) | 1973-02-01 |
| DE1966215A1 (de) | 1972-01-27 |
| FI52214B (OSRAM) | 1977-03-31 |
| YU34289B (en) | 1979-04-30 |
| NL142410B (nl) | 1974-06-17 |
| DK142844C (OSRAM) | 1981-09-28 |
| CH507938A (fr) | 1971-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO156308B (no) | Fremgangsmaate og anordning til aa oeke reaksjonsfoelsomheten og sikkerheten mot forstyrrelser i et fare-, saerlig brannmeldingsanlegg. | |
| NO153082B (no) | Apparat for stapping av en rynket roerformet omhylling | |
| NO120686B (OSRAM) | ||
| US3957850A (en) | Phenylacetic acid derivatives | |
| Elliott | 126. The stereochemistry of an oxazoline derivative of threonine. Improvement of a recent threonine synthesis | |
| NO163619B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydro- 2-heterocykloalkylpyrido(4,3)indoler. | |
| SU1156593A3 (ru) | Способ получени производных бензамида или их кислотно-аддитивных солей,или оптических изомеров | |
| NO126019B (OSRAM) | ||
| NO121950B (OSRAM) | ||
| CN115710276B (zh) | 一类7-脂肪胺取代色胺酮衍生物、其制备方法及应用 | |
| US5747521A (en) | N-cinnamoyl-2-methyl-5-methoxy-3-indoleacetic acid ester, and pharmaceutical preparation containing the same | |
| US3557127A (en) | Substituted cyclohexenes,derivatives thereof and processes for obtaining same | |
| NO158739B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-piperazinopyrimidinderivater. | |
| NO140821B (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrido-pyrimidin-derivater | |
| DK164551B (da) | Analogifremgangsmaade til fremstilling af cyclohexylthienyleddikesyreamider eller fysiologisk taalelige syreadditionssalte deraf | |
| NO141161B (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive morfinanderivater | |
| US2876232A (en) | Therapeutic agents | |
| CN115135646A (zh) | 取代的多环化合物及其药物组合物和用途 | |
| NO124430B (OSRAM) | ||
| JPS6043348B2 (ja) | 新規化合物またはその生理的に許容可能な塩及びこれらの製造法 | |
| US3775479A (en) | Amine compounds | |
| NO121213B (OSRAM) | ||
| NO137236B (no) | Analogifremgangsm}te til fremstilling av et terapeutisk virksomt piperazinyl-pyrimidin-derivat. | |
| US2793212A (en) | Substituted benzamidopiperidinopropanes | |
| US4788301A (en) | Novel allylic amines |